Cite
HARVARD Citation
Banerjee, Y. et al. (2016). Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?. Atherosclerosis. pp. 62-75. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Banerjee, Y. et al. (2016). Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?. Atherosclerosis. pp. 62-75. [Online].